Does CERTOLIZUMAB PEGOL Cause Patent ductus arteriosus? 7 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Patent ductus arteriosus have been filed in association with CERTOLIZUMAB PEGOL (Cimzia). This represents 0.0% of all adverse event reports for CERTOLIZUMAB PEGOL.
7
Reports of Patent ductus arteriosus with CERTOLIZUMAB PEGOL
0.0%
of all CERTOLIZUMAB PEGOL reports
1
Deaths
1
Hospitalizations
How Dangerous Is Patent ductus arteriosus From CERTOLIZUMAB PEGOL?
Of the 7 reports, 1 (14.3%) resulted in death, 1 (14.3%) required hospitalization.
Is Patent ductus arteriosus Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CERTOLIZUMAB PEGOL. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does CERTOLIZUMAB PEGOL Cause?
Drug ineffective (23,838)
Rheumatoid arthritis (17,782)
Pain (13,929)
Fatigue (11,438)
Off label use (10,281)
Rash (9,663)
Alopecia (9,111)
Maternal exposure during pregnancy (9,013)
Arthralgia (8,993)
Abdominal discomfort (8,615)
What Other Drugs Cause Patent ductus arteriosus?
ONDANSETRON (185)
LAMOTRIGINE (168)
PAROXETINE (168)
ACETAMINOPHEN (154)
VENLAFAXINE (135)
SERTRALINE (130)
LEVETIRACETAM (122)
FLUOXETINE (107)
METOPROLOL (104)
RAMIPRIL (98)
Which CERTOLIZUMAB PEGOL Alternatives Have Lower Patent ductus arteriosus Risk?
CERTOLIZUMAB PEGOL vs CERTOPARIN
CERTOLIZUMAB PEGOL vs CETIRIZINE
CERTOLIZUMAB PEGOL vs CETIRIZINE\PSEUDOEPHEDRINE
CERTOLIZUMAB PEGOL vs CETRIMIDE
CERTOLIZUMAB PEGOL vs CETRORELIX